BioCentury
ARTICLE | Clinical News

Aggrastat tirofiban regulatory update

August 17, 2015 7:00 AM UTC

Cardiome submitted an sNDS to Health Canada for Aggrastat tirofiban to reduce major cardiovascular events in patients with acute myocardial infarction (AMI) intended for primary percutaneous coronary ...